Byhealth Co., Ltd

Equities

300146

CNE100000Y84

Food Processing

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
16.38 CNY -0.24% Intraday chart for Byhealth Co., Ltd +4.46% -3.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Byhealth Co., Ltd Approves Cash Dividend for the Year 2023 CI
Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023. CI
Byhealth Co., Ltd Announces Profit Distribution Proposal for 2023 CI
BY-Health's 2023 Profit Rises 26% as Revenue Jumps 20% MT
Byhealth Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Byhealth Co., Ltd's Equity Buyback Plan announced on November 1, 2023. CI
Byhealth Co., Ltd announces an Equity Buyback for CNY 300 million worth of its shares. CI
Byhealth Co., Ltd authorizes a Buyback Plan. CI
Byhealth Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Provexis notes regulatory filing for Fruitflow in China AN
Provexis' Local Partner Files for New Health Function Claim for Foods in China; Rises 12% MT
Provexis plc Announces Byhealth Co., Ltd Regulatory Filing with Chinese SAMR CI
Byhealth Co. Ltd. Approves Executive Appointments CI
Byhealth Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Byhealth Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Byhealth Co.,Ltd Announces Final Dividend Share A for 2022, Payable on April 21, 2023 CI
Byhealth Co.,Ltd Approves Dividend for the Year 2022 CI
Byhealth Co.,Ltd Proposes Final Cash Dividend for 2022 CI
BY-Health Sees Up to 30% Profit Slump in 2022 MT
By-health Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
By-health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
By-health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022 CI
By-Health Co., Ltd. Approves Cash Dividend for 2021 CI
BY-Health Sticks to 2021 Dividend on Double-Digit Jump in Earnings MT
Chart Byhealth Co., Ltd
More charts
By-health Co Ltd is a China-based company principally engaged in the research, development, production, and distribution of nutrition supplements. The Company's main products include protein powders, collagen protein, vitamin C tablets, vitamin B tablets, natural vitamin E capsules, vitamin A and D soft capsules, calcium and vitamin D soft capsules, bovine colostrum calcium tablets, bone collagen calcium tablets, spirulina tablets, grape seed tablets, wheat germ oil soft capsules, deep-sea fish oil soft capsules, tuna oil soft capsules, propolis soft capsules, soybean phospholipids soft capsules and squalene soft capsules, among others. The Company distributes products both in the domestic market and to overseas markets.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
16.38 CNY
Average target price
22.99 CNY
Spread / Average Target
+40.37%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300146 Stock
  4. News Byhealth Co., Ltd
  5. BY-Health Sees Up to 30% Profit Slump in 2022